Eirgen Pharma is delighted to announce our attendance at DCAT Week 2026, taking place in New York City from March 23rd to March 25th - the premier event where global pharmaceutical and biopharmaceutical leaders come together for strategic meetings, high-value collaborations, and forward-thinking industry insights.

As a trusted CDMO partner for oral solid dose products, we're looking forward to engaging with companies focused on accelerating development timelines, de-risking supply chains, and scaling commercial supply with confidence.

Building the Future of High-Potency Manufacturing

At DCAT Week, our team will highlight Eirgen's expanding capabilities across development, tech transfer, and commercial manufacturing - supported by significant investments designed to meet the industry's demand for flexible, high-quality long-term capacity.

---

Meet Our Team At DCAT 2026

Meet with members of our executive team and business development team;

• Damien Burke, Chief Executive Officer (CEO)

• James Murphy, Chief Operations Officer (COO)

• Dr. Sarah Wade, Business Development and Alliance Manager

📍 The Fitzpatrick Hotel, Manhattan

DCAT Week is all about strategic conversations - and we're ready to discuss how Eirgen can support your upcoming programs with smarter, more agile, and more resilient solutions.

Schedule time with our team to explore;

• New Product Introductions

• Expansion of Existing Supply

• Tech Transfer Opportunities

• Capacity Planning for 2026-2028

• Long-term strategic partnerships

📧 Email bd@eirgen.com to secure your meeting request.

---